08 Aug Ori Biotech
Ori Biotech is revolutionizing cell and gene therapy manufacturing by pioneering flexible process discovery alongside seamless transition to scalable commercialization. Ori has developed a proprietary, full stack manufacturing platform that closes, automates, standardizes and digitizes CGT manufacturing, allowing therapy developers to research, develop and bring their products to market at commercial scale on the same platform. The promise of the innovative Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining innovation across three pillars: 1) biology, 2) engineering, and 3) digital. Ori’s biology-first approach puts primary focus on the biology vs constraining the biology due to inflexible technology. This allows the Ori platform to be an enabler instead of an inhibiter to quickly getting to scale.